Cargando…
Effects of an oral synbiotic on the gastrointestinal immune system and microbiota in patients with diarrhea-predominant irritable bowel syndrome
PURPOSE: Diarrhea-predominant irritable bowel syndrome (IBS-D) is a common functional gastrointestinal disorder. Probiotics and synbiotics have been shown to improve symptoms of IBS, although mechanisms of action are currently not understood. METHODS: We investigated the effects of a 4-week oral syn...
Autores principales: | Moser, Adrian Mathias, Spindelboeck, Walter, Halwachs, Bettina, Strohmaier, Heimo, Kump, Patrizia, Gorkiewicz, Gregor, Högenauer, Christoph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6768888/ https://www.ncbi.nlm.nih.gov/pubmed/30251020 http://dx.doi.org/10.1007/s00394-018-1826-7 |
Ejemplares similares
-
Mucosal biopsy shows immunologic changes of the colon in patients with early MS
por: Moser, Adrian Mathias, et al.
Publicado: (2017) -
Effects of high doses of vitamin D(3) on mucosa-associated gut microbiome vary between regions of the human gastrointestinal tract
por: Bashir, Mina, et al.
Publicado: (2015) -
Targeted therapies for diarrhea-predominant irritable bowel syndrome
por: Olden, Kevin W
Publicado: (2012) -
Diagnosis and treatment of diarrhea-predominant irritable bowel syndrome
por: Lacy, Brian E
Publicado: (2016) -
Eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome
por: Özdener, Ayşe Elif, et al.
Publicado: (2017)